BusinessChromaDex Sells its Analytical Testing Business to LabCorp, to Accelerate the Expansion of Nicotinamide Riboside and its Other Patented Ingredient TechnologiesBy Nasdaq OMXAug 23, 2017, 12:30 PM UTC
BusinessChromaDex Announces Closing of Third and Final Tranche of the $25 Million Strategic Investment Led by Mr. Li Ka-shing and Appoints Two Additional Board MembersBy Nasdaq OMXAug 21, 2017, 10:30 AM UTC
BusinessNew York City Gets First Concierge Vitamin IV Therapy ServiceBy Nasdaq OMXAug 10, 2017, 2:30 PM UTC
BusinessNature’s Sunshine Products Reports Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 8, 2017, 8:50 PM UTC
BusinessNature’s Sunshine Products to Announce Second Quarter 2017 Financial Results and to Host Conference Call on Tuesday, August 8thBy Nasdaq OMXAug 1, 2017, 12:01 PM UTC
BusinessChromaDex Sponsors Global Gathering of Scientific Leaders in NAD+ Metabolism and Signaling at the 2017 Federation of American Societies for Experimental Biology ConferenceBy Nasdaq OMXJul 10, 2017, 10:30 AM UTC
BusinessChromaDex Appoints Harvard Medical School Professor of Neurology, Dr. Rudolph Tanzi, to the Scientific Advisory BoardBy Nasdaq OMXJun 27, 2017, 10:30 AM UTC
BusinessPrinova Acquires Lycored’s United Kingdom and China-based Premix Manufacturing LocationsBy Nasdaq OMXJun 27, 2017, 12:10 AM UTC
